KRISHNA MOHAN PUVVADA
Why India being a $300-billion bioeconomy by 2030 is just the tip of the icebergIn India’s quest to be sustainable, biotechnology can be a major ally. Krishna Mohan Puvvada, Regional President-India, Novozymes, explains...
- Load More